Fk. Darkwa et Dd. Smyth, INHIBITION OF THE NATRIURETIC ACTION OF THE IMIDAZOLINE RECEPTOR AGONIST MOXONIDINE BY INDOMETHACIN IN THE RAT, Pharmacology, 51(6), 1995, pp. 347-355
Indometacin pretreatment potentiates the natriuretic action of the mix
ed alpha(2)-adrenoceptor/imidazoline receptor agonist clonidine. In th
e present study we determined the effects of indometacin pretreatment
on natriuretic actions of the selective Ii imidazoline receptor agonis
t. In anaesthetized rats, an intrarenal infusion of moxonidine (0, 0.3
, 1, and 3 nmol/kg/min) increased urine flow rate and sodium excretion
without altering blood pressure or creatinine clearance. Indometacin
pretreatment abolished the subsequent natriuretic response to an intra
renal infusion of moxonidine (1 nmol/kg/min) without altering blood pr
essure or creatinine clearance. Administration of prostaglandin E(2),
at an infusion rate (1 mu g/kg/min) which alone failed to alter urine
flow rate, sodium excretion, blood pressure, or creatinine clearance,
partially, but not completely, restored the natriuretic response to mo
xonidine. The ability of indometacin pretreatment to potentiate natriu
retic actions of an alpha(2)-adrenoceptor agonist and to attenuate tho
se of an imidazoline agonist indicates that these two receptors in the
kidney are unique and may serve distinct functions in the regulation
of sodium and water excretion.